Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA helicase is an essential enzyme responsible for unwinding double-stranded nucleic acids using energy derived from ATP hydrolysis. This process is fundamental during DNA replication, where the enzyme separates parental strands at the replication fork so that each can serve as a template for new synthesis. In prokaryotes like E. coli, DnaB acts as the main replicative DNA helicase; in eukaryotes, this role is filled by the mini-chromosome maintenance complex (MCM). Beyond replication, various specialized forms of DNA helicase participate in repair, recombination, and other aspects of genome metabolism. Structurally, most active forms are hexameric ring-shaped complexes with conserved sequence motifs involved in ATP binding/hydrolysis and nucleic acid interaction—these motifs define six major superfamilies (SF1–SF6). The directionality of movement along nucleic acids varies among family members. Dysfunctional or mutated human homologs have been implicated in several diseases characterized by chromosomal instability—including certain cancers and rare premature aging syndromes—making them both important biological markers and potential therapeutic targets[1][4][5][7].
Drugs targeting DNA helicases would typically act by inhibiting ATP hydrolysis, blocking the enzyme’s ability to unwind double-stranded nucleic acids, thereby halting replication or repair processes essential for cell survival or viral propagation[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA helicase.